Dr Reddys Laboratories Share Price Today - Live Blog for May 13, 2025

The stock of Dr Reddys Laboratories Ltd is facing a -0.01% decline and is currently trading at ₹1,207.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.10% upswing and is currently trading at ₹1,208.85, indicating strong market sentiment.

The stock of Dr Reddys Laboratories Ltd is facing a -0.20% decline and is currently trading at ₹1,207.10 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,209.55. With the stock's PE at 17.6400 and the industry PE at 33.5236, investors are weighing their options.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.07%, and as of now, it's trading at ₹1,208.75 per share. This upward trajectory is attracting keen interest from investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.32% drop, and it's now trading at ₹1,207.90 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.14% boost, with the current market value at ₹1,209.80 per share. This surge has not gone unnoticed by investors.

With a -0.26% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,208.15. The stock is currently trading at a PE of 17.6400, while the industry PE is 33.5236, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,211.40 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd witnessed a -0.08% drop in its share price and is currently trading at ₹1,211.10. With the stock's PE at 17.6400 and the industry PE at 33.5236, investors are weighing their options.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.13%, with its current market value per share resting at ₹1,213.10. This development highlights the stock's appeal to investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.45% decline, and it currently trades at ₹1,213.50 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd share price has declined by -0.05%, and it's currently trading at ₹1,218.25. The stock maintains a PE of 17.6400, while the industry PE is 33.5236, prompting discussions about its valuation.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.02% gain, with the share price now at ₹1,220.10. Notably, the stock's PE ratio stands at 17.6400, and its Return on Equity (ROE) is 16.8559%.

With a -0.05% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,216.20. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.6400, while the industry PE is 33.5236.

Dr Reddys Laboratories Ltd witnessed a -0.05% drop in its share price and is currently trading at ₹1,216.20. With the stock's PE at 17.6400 and the industry PE at 33.5236, investors are weighing their options.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.03% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,218.25 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.03%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,217.55, and market participants are assessing the implications. The stock has a PE ratio of 17.6400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.23%, reaching a current market price of ₹1,218.85. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has fallen by -0.30%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,221.30, and market participants are assessing the implications. The stock has a PE ratio of 17.6400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has dropped by -0.94%, a development that warrants careful analysis. Presently trading at ₹1,224.00, investors are assessing whether this presents an opportunity or a risk.

The stock of Dr Reddys Laboratories Ltd suffered a -0.13% decline, and it currently trades at ₹1,236.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a -0.18% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,237.00. Investors should examine the factors driving this decline. The stock's PE ratio is 17.6400, whereas the industry PE ratio stands at 33.5236.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.27% increase and currently trading at ₹1,238.10 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd witnessed a notable 1.08% surge in its share price and is presently trading at ₹1,235.10, captivating the attention of market participants.

Following a noteworthy 2.06% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,220.00. When it comes to valuation, this stock has a PE ratio of 17.6400, with the industry PE ratio at 33.5236.